跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 70,352 条关于
“Wet Age-Related Macular Degeneration”
全部
70,352
临床试验
54,461
药物
1,182
机构
575
资讯
14,134
9个月前
FDA Approves First CRISPR-Cas13 RNA Editing Trial for Wet Age-Related Macular Degeneration
5个月前
Merck Initiates Pivotal Phase 2b/3 Trial for Novel Bispecific Antibody MK-8748 in Wet Age-Related Macular Degeneration
2年前
UNITY Biotechnology Announces 48-Week Results from Phase 2 ENVISION Study of UBX1325 in Patients with Wet Age-Related Macular Degeneration
去年
Essex Bio-Technology Completes Phase 3 Study for Wet-AMD Treatment
去年
Alteogen's Aflibercept Biosimilar Eyluxvi Receives Positive Opinion from European Medicines Agency
去年
ANGPTL4 Overexpression May Limit Anti-VEGF Therapy Efficacy in Wet AMD
12天前
EyePoint's DURAVYU Misses Primary Endpoint in Phase 3 LUGANO Trial for Wet AMD
去年
Opthea Reports Positive Phase 1b DME Trial Results
去年
Samsung Bioepis' OfubizTM (Aflibercept) Biosimilar Approved in Europe for Ophthalmic Diseases
11个月前
EyePoint Pharmaceuticals Raises $150 Million to Advance DURAVYU Phase 3 Trials for Retinal Diseases
第 1 页，共 1414 页
上一页
下一页
